Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kaijin Technology is a prominent Chinese medical device manufacturer specializing in extracorporeal shock wave technology for urological and orthopedic applications. Established in 1996, the company is a leader in the development of high-performance lithotripters used for the non-invasive treatment of kidney and urinary stones. Its product portfolio includes the KJ series of electromagnetic and hydraulic shock wave lithotripters, as well as specialized shock wave therapy systems for orthopedic rehabilitation and chronic pain management. Kaijin's technology is widely utilized in clinical settings across China and is exported to numerous international markets. The company is recognized for its innovation in shock wave source stability and integrated imaging systems for precise stone localization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kaijin Technology.